HEALTH MEDIA NOW-RICHARD GABRIEL-NEW PRECISION CANCER THERAPIES

Please join us May 8, 2019 at 4:00 p.m. California time for a live show with host Denise Messenger.  Our special guest is Richard Gabriel, CEO of the Tumor Genesis Company.  Richard Gabriel has worked at nearly all levels in the life science and specialty chemical industries from manufacturing, research and development, scale-up, FDA compliance, government contracting, public company SEC compliance, regulatory, business development, marketing, sales and team building. His broad experience allows him to look at complicated business and technical situations and map a clear course of action. He is currently a Board Member of Precision Therapeutics (NASDAQ: AIPT) and an Operating office for TumorGenesis a AIPT wholly owned subsidiary focused on cancer cell capture, culture and drug screening. He is also COO and Cofounder of GLG Pharma, a AIPT partner in cancer discovery, development and approvals. He has assisted a number of start-up companies as a mentor, sat on boards of directors and was advisor to large corporations regarding technology innovation and development of new market and business opportunities. Mr. Gabriel has a Bachelor of Science (Chemistry) degree from Ohio Dominican College and a Masters in Business Administration from Suffolk University’s Executive MBA Program. He is the author of numerous patents and has presented on cGMP compliance, team building and management in the pharmaceutical industry as well as many other topics. You asked for it and we deliver.